Editorial: Fecal granins in IBS: Cause or indicator of intestinal or colonic irritation

American Journal of Gastroenterology

Volumn 107, Issue 3, 2012, Pages 448-450

  Camilleri, Michael ^a  

^a Clinical Enteric Neuroscience Translational and Epidemiological Research Mayo Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMOGRANIN A; CHROMOGRANIN B;

ARTICLE; DIARRHEA; FECES ANALYSIS; HUMAN; IRRITABLE COLON; MALABSORPTION; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; PROTEIN INTOLERANCE; PROTEIN SECRETION;

CHROMOGRANINS; FECES; FEMALE; HUMANS; IRRITABLE BOWEL SYNDROME; MALE;

EID: 84857828195     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2011.465     Document Type: Article

References (33)

1. Öhman L, Stridsberg M, Isaksson S et al. Altered levels of fecal chromogranins and secretogranins in IBS: relevance for pathophysiology and symptoms? Am J Gastroenterol 2012;107:440-7 (this issue).
2. Hendy GN, Bevan S, Mattei MG et al. Chromogranin A. Clin Invest Med 1995; 18: 47-65.
3. Camilleri M, McKinzie S, Busciglio I et al. Prospective study of motor, sensory, psychologic, and autonomic functions in patients with irritable bowel syndrome. Clin Gastroenterol Hepatol 2008; 6: 772-81.
4. Sidhu R, McAlindon ME, Leeds JS et al. The role of serum chromogranin A in diarrhoea predominant irritable bowel syndrome. J Gastrointestin Liver Dis 2009; 18: 23-6.
5. El-Salhy M, Lomholt-Beck B, Gundersen TD. High chromogranin A cell density in the colon of patients with lymphocytic colitis. Mol Med Report 2011; 4: 603-5.
6. Moyana TN, Shukoor S. Gastrointestinal endocrine cell hyperplasia in celiac disease: a selective proliferative process of serotonergic cells. Mod Pathol 1991; 4: 419-23.
7. Pietroletti R, Bishop AE, Carlei F et al. Gut endocrine cell population in coeliac disease estimated by immunocytochemistry using a monoclonal antibody to chromogranin. Gut 1986; 27: 838-43. (Pubitemid 16058505)
8. Eriksson B, Oberg K, Stridsberg M. Tumor markers in neuroendocrine tumors. Digestion 2000; 62 (Suppl.1): 33-8. (Pubitemid 30665937)
9. Spiller RC, Jenkins D, Thornley JP et al. Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome. Gut 2000; 47: 804-11.
10. Dunlop SP, Jenkins D, Neal KR et al. Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBS. Gastroenterology 2003; 125: 1651-9. (Pubitemid 37500429)
11. Kidd M, Modlin IM, Gustafsson BI et al. Luminal regulation of normal and neoplastic human EC cell serotonin release is mediated by bile salts, amines, tastants, and olfactants. Am J Physiol 2008; 295: G260-72.
12. Peregrin AT, Ahlman H, Jodal M et al. Involvement of serotonin and calcium channels in the intestinal fluid secretion evoked by bile salt and cholera toxin. Br J Pharmacol 1999; 127: 887-94. (Pubitemid 29295347)
13. Painter NS. Irritable or irritated bowel. BMJ 1972; 2: 46.
14. Camilleri M, Prather CM. The irritable bowel syndrome: mechanisms and a practical approach to management. Ann Intern Med 1992; 116: 1001-8.
15. Frissora CL, Koch KL. Symptom overlap and comorbidity of irritable bowel syndrome with other conditions. Curr Gastroenterol Rep 2005; 7: 264-71. (Pubitemid 41223338)
16. Farup PG, Monsbakken KW, Vandvik PO. Lactose malabsorption in a population with irritable bowel syndrome: prevalence and symptoms. A case-control study. Scand J Gastroenterol 2004; 39: 645-9. (Pubitemid 38916240)
17. Rumessen JJ, Gudmand-H ø yer E. Functional bowel disease: malabsorption and abdominal distress aft er ingestion of fructose, sorbitol, and fructosesorbitol mixtures. Gastroenterology 1988; 95: 694-700.
18. Nelis GF, Vermeeren MA, Jansen W. Role of fructose-sorbitol malabsorption in the irritable bowel syndrome. Gastroenterology 1990; 99: 1016-20. (Pubitemid 20338459)
19. Wahnschaffe U, Schulzke JD, Zeitz M et al. Predictors of clinical response to gluten-free diet in patients diagnosed with diarrhea-predominant irritable bowel syndrome. Clin Gastroenterol Hepatol 2007; 5: 844-50. (Pubitemid 47031067)
20. Oddsson E, Rask-Madseu J, Krag E. A secretory epithelium of the small intestine with increased sensitivity to bile acids in irritable bowel syndrome associated with diarrhoea. Scand J Gastroentol 1978; 13: 409-16. (Pubitemid 8354130)
21. Hofmann AF. The syndrome of ileal disease and the broken enterohepatic circulation: cholerheic enteropathy. Gastroenterology 1967; 52: 752-7.
22. Wedlake L, Hern R, Russell D et al. Systematic review: the prevalence of idiopathic bile acid malabsorption as diagnosed by SeHCAT scanning in patients with diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther 2009; 30: 707-17.
23. Stephen AM, Haddad AC, Phillips SF. Passage of carbohydrate into the colon. Direct measurements in humans. Gastroenterology 1983; 85: 589-95. (Pubitemid 13033115)
24. Spiller RC, Brown ML, Phillips SF. Decreased fluid tolerance, accelerated transit, and abnormal motility of the human colon induced by oleic acid. Gastroenterology 1986; 91: 100-7. (Pubitemid 16086661)
25. Kamath PS, Hoepfner MT, Phillips SF. Short-chain fatty acids stimulate motility of the canine ileum. Am J Physiol 1987; 253: G427-33.
26. Karaki S, Mitsui R, Hayashi H et al. Short-chain fatty acid receptor, GPR43, is expressed by enteroendocrine cells and mucosal mast cells in rat intestine. Cell Tissue Res 2006; 324: 353-60. (Pubitemid 43673476)
27. Fukumoto S, Tatewaki M, Yamada T et al. Short-chain fatty acids stimulate colonic transit via intraluminal 5-HT release in rats. Am J Physiol 2003; 284: R1269-76. (Pubitemid 36457570)
28. Mitsui R, Ono S, Karaki S et al. Neural and non-neural mediation of propionate-induced contractile responses in the rat distal colon. Neurogastroenterol Motil 2005; 17: 585-94. (Pubitemid 41076001)
29. Gibson PR, Shepherd SJ. Evidence-based dietary management of functional gastrointestinal symptoms: the FODMAP approach. J Gastroenterol Hepatol 2010; 25: 252-8.
30. Ohman L, Simrén M. Pathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions. Nat Rev Gastroenterol Hepatol 2010; 7: 163-73.
31. Peeters M, Van den Brande J, Francque S. Diarrhea and the rationale to use sandostatin. Acta Gastroenterol Belg 2010; 73: 25-36.
32. Shooshtarizadeh P, Zhang D, Chich JF et al. The antimicrobial peptides derived from chromogranin/secretogranin family, new actors of innate immunity. Regul Pept 2010; 165: 102-10.
33. Montero-Hadjadje M, Elias S, Chevalier L et al. Chromogranin A promotes peptide hormone sorting to mobile granules in constitutively and regulated secreting cells: role of conserved N-and C-terminal peptides. J Biol Chem 2009; 284: 12420-31.